Related Experiment Video

Updated: Jul 28, 2026

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration
05:37

Partial Lobular Hepatectomy: A Surgical Model for Morphologic Liver Regeneration

Published on: May 31, 2018

Role of macrophages in acetaminophen (paracetamol)-induced hepatotoxicity

R D Goldin1, I D Ratnayaka, C S Breach

  • 1Division of Pathology Sciences, St Mary's Hospital Medical School, London, UK.

The Journal of Pathology
|August 1, 1996
PubMed

Insights

Macrophages play a direct role in early acetaminophen-induced liver damage. Eliminating these immune cells significantly reduced hepatotoxicity in a mouse model, suggesting a novel therapeutic target for acetaminophen toxicity.

Area of Science:

  • Hepatology
  • Immunology
  • Toxicology

Background:

  • Acetaminophen (paracetamol) overdose is a leading cause of acute liver failure.
  • Hepatotoxicity research has focused on toxic metabolites produced by hepatocytes.
  • Recent findings indicate macrophages secrete increased tumor necrosis factor (TNF) when exposed to acetaminophen.

Purpose of the Study:

  • To investigate the direct role of macrophages in acetaminophen-induced hepatotoxicity.
  • To determine if eliminating hepatic macrophages mitigates liver damage caused by acetaminophen.

Main Methods:

  • Utilized a mouse model to deplete over 99% of hepatic macrophages using liposomes containing dichloromethylene disphosphonate (DMDP).
  • Administered acetaminophen intraperitoneally to macrophage-depleted and control mice.
  • Assessed acetaminophen-induced liver damage biochemically and histologically at various time points (0.5, 1, 2, and 4 hours).

Main Results:

  • Macrophage-depleted mice exhibited significantly reduced liver damage at 0.5, 1, and 2 hours post-acetaminophen administration compared to controls.
  • No significant difference in liver damage was observed between groups at 4 hours.
  • The results suggest an early, direct contribution of macrophages to acetaminophen hepatotoxicity.

Conclusions:

  • Macrophages play an early and direct role in mediating acetaminophen-induced liver damage.
  • This finding is consistent with the known role of macrophages in alcohol-induced liver damage.
  • Targeting macrophages may represent a novel therapeutic strategy for acetaminophen toxicity.

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

Related Concept Videos

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...